» Authors » Chanyeong Lee

Chanyeong Lee

Explore the profile of Chanyeong Lee including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 4
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Chun J, Yoon D, Nowakowska A, Lee H, Lee C, Kim J, et al.
Vaccine . 2024 Sep; 42(26):126355. PMID: 39260058
Although the coronavirus pandemic has ended, new variants of concern (VOCs) continue to emerge. Therefore, novel vaccines targeting VOCs are highly warranted. We initially constructed three recombinant baculovirus-vectored vaccines (AcHERV-COVID19S)...
2.
Park S, Seo J, Han K, Lee B, Lee C, Kim B, et al.
Vaccine X . 2024 Sep; 20:100545. PMID: 39221182
The coronavirus disease 2019 (COVID-19) emerged as a major global health crisis, posing significant health, economic, and social challenges. Vaccine development has been a crucial response to the severe-acute-respiratory-syndrome-related coronavirus-2...
3.
Nowakowska A, Lee S, Kim M, Chun J, Kim S, Kim B, et al.
Front Immunol . 2024 Jul; 15:1359209. PMID: 39040104
Introduction: Although the safety and effectiveness of COVID-19 vaccination during pregnancy have been proven, there is still little data explaining neonatal outcomes of maternal pre-pregnancy vaccination. Methods: Here, we investigated...
4.
Lee C, Kim M, Chun J, Kim S, Yoon D, Lee H, et al.
Vaccines (Basel) . 2024 Mar; 12(3). PMID: 38543967
Varicella-zoster virus (VZV) poses lifelong risks, causing varicella and herpes zoster (HZ, shingles). Currently, varicella and HZ vaccines are predominantly live attenuated vaccines or adjuvanted subunit vaccines utilizing VZV glycoprotein...
5.
Lee H, Chun J, Kim S, Aleksandra N, Lee C, Yoon D, et al.
J Microbiol Biotechnol . 2023 Oct; 34(1):185-191. PMID: 37830223
Various types of vaccines have been developed against COVID-19, including vector vaccines. Among the COVID-19 vaccines, AstraZeneca's chimpanzee adenoviral vaccine was the first to be commercialized. For viral vector vaccines,...
6.
Jang Y, Cho H, Chun J, Park K, Nowakowska A, Kim J, et al.
Vaccine . 2023 Jan; 41(6):1223-1231. PMID: 36631359
After severe acute respiratory syndrome coronavirus-2 (SARS-CoV2) made the world tremble with a global pandemic, SARS-CoV2 vaccines were developed. However, due to the coronavirus's intrinsic nature, new variants emerged, such...